Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation.

van der Heiden PLJ, Arbous MS, van Beers EJ, van den Bergh WM, le Cessie S, Demandt AMP, Eefting M, Hess C, Kusadasi N, Marijt WAF, van Mook WNKA, Müller MCA, Tuinman PR, van Vliet M, van Westerloo DJ, Blijlevens NMA; HEMA-ICU Study Group.

Bone Marrow Transplant. 2018 Aug 6. doi: 10.1038/s41409-018-0277-3. [Epub ahead of print]

PMID:
30082850
2.

[Professional HIV testing].

Usadel S, Müller MC.

MMW Fortschr Med. 2018 Jun;160(Suppl 2):14-18. doi: 10.1007/s15006-018-0647-1. Review. German. No abstract available.

PMID:
29943335
3.

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.

Saussele S, Richter J, Guilhot J, Gruber FX, Hjorth-Hansen H, Almeida A, Janssen JJWM, Mayer J, Koskenvesa P, Panayiotidis P, Olsson-Strömberg U, Martinez-Lopez J, Rousselot P, Vestergaard H, Ehrencrona H, Kairisto V, Machová Poláková K, Müller MC, Mustjoki S, Berger MG, Fabarius A, Hofmann WK, Hochhaus A, Pfirrmann M, Mahon FX; EURO-SKI investigators.

Lancet Oncol. 2018 Jun;19(6):747-757. doi: 10.1016/S1470-2045(18)30192-X. Epub 2018 May 4.

PMID:
29735299
4.

Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.

Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre PD, Paquette R, Chuah C, Nicolini FE, Apperley JF, Khoury HJ, Talpaz M, DeAngelo DJ, Abruzzese E, Rea D, Baccarani M, Müller MC, Gambacorti-Passerini C, Lustgarten S, Rivera VM, Haluska FG, Guilhot F, Deininger MW, Hochhaus A, Hughes TP, Shah NP, Kantarjian HM.

Blood. 2018 Jul 26;132(4):393-404. doi: 10.1182/blood-2016-09-739086. Epub 2018 Mar 22.

5.

Effect of On-Demand vs Routine Nebulization of Acetylcysteine With Salbutamol on Ventilator-Free Days in Intensive Care Unit Patients Receiving Invasive Ventilation: A Randomized Clinical Trial.

van Meenen DMP, van der Hoeven SM, Binnekade JM, de Borgie CAJM, Merkus MP, Bosch FH, Endeman H, Haringman JJ, van der Meer NJM, Moeniralam HS, Slabbekoorn M, Muller MCA, Stilma W, van Silfhout B, Neto AS, Ter Haar HFM, Van Vliet J, Wijnhoven JW, Horn J, Juffermans NP, Pelosi P, Gama de Abreu M, Schultz MJ, Paulus F.

JAMA. 2018 Mar 13;319(10):993-1001. doi: 10.1001/jama.2018.0949.

6.

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV.

Saussele S, Hehlmann R, Fabarius A, Jeromin S, Proetel U, Rinaldetti S, Kohlbrenner K, Einsele H, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Oppliger Leibundgut E, Heim D, Krause SW, Hofmann WK, Hasford J, Pfirrmann M, Müller MC, Hochhaus A, Lauseker M.

Leukemia. 2018 May;32(5):1222-1228. doi: 10.1038/s41375-018-0055-7. Epub 2018 Feb 26.

7.

Time trend analysis of long term outcome of patients with haematological malignancies admitted at dutch intensive care units.

de Vries VA, Müller MCA, Sesmu Arbous M, Biemond BJ, Blijlevens NMA, Kusadasi N, Choi GCW, Vlaar APJ, van Westerloo DJ, Kluin-Nelemans HC, van den Bergh WM; HEMA-ICU Study Group.

Br J Haematol. 2018 Apr;181(1):68-76. doi: 10.1111/bjh.15140. Epub 2018 Feb 22.

PMID:
29468848
8.

Distinct domains of the AVRPM3A2/F2 avirulence protein from wheat powdery mildew are involved in immune receptor recognition and putative effector function.

McNally KE, Menardo F, Lüthi L, Praz CR, Müller MC, Kunz L, Ben-David R, Chandrasekhar K, Dinoor A, Cowger C, Meyers E, Xue M, Zeng F, Gong S, Yu D, Bourras S, Keller B.

New Phytol. 2018 Apr;218(2):681-695. doi: 10.1111/nph.15026. Epub 2018 Feb 17.

PMID:
29453934
9.

Non-parent of Origin Expression of Numerous Effector Genes Indicates a Role of Gene Regulation in Host Adaption of the Hybrid Triticale Powdery Mildew Pathogen.

Praz CR, Menardo F, Robinson MD, Müller MC, Wicker T, Bourras S, Keller B.

Front Plant Sci. 2018 Jan 30;9:49. doi: 10.3389/fpls.2018.00049. eCollection 2018.

10.

[Infectiological Rapid Tests in Practices and at Home].

Spinner CD, Müller MC, Lange B.

Dtsch Med Wochenschr. 2018 Feb;143(3):157-160. doi: 10.1055/s-0043-123608. Epub 2018 Feb 6. German.

PMID:
29409084
11.

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Schütz C, Inselmann S, Saussele S, Dietz CT, Müller MC, Eigendorff E, Brendel CA, Metzelder SK, Brümmendorf TH, Waller C, Dengler J, Goebeler ME, Herbst R, Freunek G, Hanzel S, Illmer T, Wang Y, Lange T, Finkernagel F, Hehlmann R, Huber M, Neubauer A, Hochhaus A, Guilhot J, Mahon FX, Pfirrmann M, Burchert A.

Leukemia. 2018 Apr;32(4):1054. doi: 10.1038/leu.2017.348. Epub 2018 Jan 30.

PMID:
29381150
12.

Ponatinib in chronic myeloid leukemia (CML): Consensus on patient treatment and management from a European expert panel.

Müller MC, Cervantes F, Hjorth-Hansen H, Janssen JJWM, Milojkovic D, Rea D, Rosti G.

Crit Rev Oncol Hematol. 2017 Dec;120:52-59. doi: 10.1016/j.critrevonc.2017.10.002. Epub 2017 Oct 8. Review.

13.

Induced Hypertension for Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.

Gathier CS, van den Bergh WM, van der Jagt M, Verweij BH, Dankbaar JW, Müller MC, Oldenbeuving AW, Rinkel GJE, Slooter AJC; HIMALAIA Study Group.

Stroke. 2018 Jan;49(1):76-83. doi: 10.1161/STROKEAHA.117.017956. Epub 2017 Nov 20.

PMID:
29158449
14.

The management of critically ill patients with haematological malignancies.

Kusadasi N, Müller MCA, van Westerloo DJ, Broers AEC, Hilkens MGEC, Blijlevens On Behalf Of The Hema-Icu Study Group NMA.

Neth J Med. 2017 Sep;75(7):265-271. Review.

15.

High BCR-ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib.

Vigneri P, Stagno F, Stella S, Cupri A, Forte S, Massimino M, Antolino A, Siragusa S, Mannina D, Impera SS, Musolino C, Malato A, Mineo G, Tomaselli C, Murgano P, Musso M, Morabito F, Molica S, Martino B, Manzella L, Müller MC, Hochhaus A, Raimondo FD.

Clin Cancer Res. 2017 Dec 1;23(23):7189-7198. doi: 10.1158/1078-0432.CCR-17-0962. Epub 2017 Sep 19.

PMID:
28928163
16.

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Hehlmann R, Lauseker M, Saußele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, Hossfeld DK, Nerl C, Gratwohl A, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Müller MC, Jeromin S, Proetel U, Kohlbrenner K, Voskanyan A, Rinaldetti S, Seifarth W, Spieß B, Balleisen L, Goebeler MC, Hänel M, Ho A, Dengler J, Falge C, Kanz L, Kremers S, Burchert A, Kneba M, Stegelmann F, Köhne CA, Lindemann HW, Waller CF, Pfreundschuh M, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Pezzutto A, Schenk M, Brossart P, Geer T, Bildat S, Schäfer E, Hochhaus A, Hasford J.

Leukemia. 2017 Nov;31(11):2398-2406. doi: 10.1038/leu.2017.253. Epub 2017 Aug 14.

17.

[Using thromboelastography to measure coagulation following massive blood loss].

Müller MCA, Ponjee GAE.

Ned Tijdschr Geneeskd. 2017;161:D1380. Dutch.

PMID:
28745251
18.

Recognition and Management of Hemostatic Disorders in Critically Ill Patients Needing to Undergo an Invasive Procedure.

Müller MCA, Stanworth SJ, Coppens M, Juffermans NP.

Transfus Med Rev. 2017 Oct;31(4):223-229. doi: 10.1016/j.tmrv.2017.05.008. Epub 2017 Jun 15. Review.

PMID:
28647217
19.

Data sets for author name disambiguation: an empirical analysis and a new resource.

Müller MC, Reitz F, Roy N.

Scientometrics. 2017;111(3):1467-1500. doi: 10.1007/s11192-017-2363-5. Epub 2017 Mar 27.

20.

The Impact of Steroidal Glycoalkaloids on the Physiology of Phytophthora infestans, the Causative Agent of Potato Late Blight.

Dahlin P, Müller MC, Ekengren S, McKee LS, Bulone V.

Mol Plant Microbe Interact. 2017 Jul;30(7):531-542. doi: 10.1094/MPMI-09-16-0186-R. Epub 2017 May 16.

21.

Evaluation of the new C-arm guiding system ClearGuide® in an orthopaedic and trauma operating theatre.

Müller MC, Frege S, Strauss AC, Gathen M, Windemuth M, Striepens EN.

Int J Med Robot. 2017 Sep;13(3). doi: 10.1002/rcs.1820. Epub 2017 Apr 3.

PMID:
28371198
22.

Measuring Energy Expenditure in extracorporeal lung support Patients (MEEP) - Protocol, feasibility and pilot trial.

Wollersheim T, Frank S, Müller MC, Skrypnikov V, Carbon NM, Pickerodt PA, Spies C, Mai K, Spranger J, Weber-Carstens S.

Clin Nutr. 2018 Feb;37(1):301-307. doi: 10.1016/j.clnu.2017.01.001. Epub 2017 Jan 16.

PMID:
28143666
23.

Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy.

Proschmann R, Baldow C, Rothe T, Suttorp M, Thiede C, Tauer JT, Müller MC, Hochhaus A, Roeder I, Glauche I.

Haematologica. 2017 Feb;102(2):e39-e42. doi: 10.3324/haematol.2016.154138. Epub 2016 Nov 17. No abstract available.

24.

Bone Morphogenetic Protein-2, But Not Mesenchymal Stromal Cells, Exert Regenerative Effects on Canine and Human Nucleus Pulposus Cells.

Bach FC, Miranda-Bedate A, van Heel FW, Riemers FM, Müller MC, Creemers LB, Ito K, Benz K, Meij BP, Tryfonidou MA.

Tissue Eng Part A. 2017 Mar;23(5-6):233-242. doi: 10.1089/ten.TEA.2016.0251. Epub 2016 Dec 12.

PMID:
27829314
25.

Supplemented base medium containing Amburana cearensis associated with FSH improves in vitro development of isolated goat preantral follicles.

Gouveia BB, Macedo TJ, Santos JM, Barberino RS, Menezes VG, Müller MC, Almeida JR, Figueiredo JR, Matos MH.

Theriogenology. 2016 Sep 15;86(5):1275-84. doi: 10.1016/j.theriogenology.2016.04.068. Epub 2016 Apr 27.

PMID:
27287468
26.

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale.

Cross NC, White HE, Ernst T, Welden L, Dietz C, Saglio G, Mahon FX, Wong CC, Zheng D, Wong S, Wang SS, Akiki S, Albano F, Andrikovics H, Anwar J, Balatzenko G, Bendit I, Beveridge J, Boeckx N, Cerveira N, Cheng SM, Colomer D, Czurda S, Daraio F, Dulucq S, Eggen L, El Housni H, Gerrard G, Gniot M, Izzo B, Jacquin D, Janssen JJ, Jeromin S, Jurcek T, Kim DW, Machova-Polakova K, Martinez-Lopez J, McBean M, Mesanovic S, Mitterbauer-Hohendanner G, Mobtaker H, Mozziconacci MJ, Pajič T, Pallisgaard N, Panagiotidis P, Press RD, Qin YZ, Radich J, Sacha T, Touloumenidou T, Waits P, Wilkinson E, Zadro R, Müller MC, Hochhaus A, Branford S.

Leukemia. 2016 Sep;30(9):1844-52. doi: 10.1038/leu.2016.90. Epub 2016 Apr 25.

27.

Avirulence Genes in Cereal Powdery Mildews: The Gene-for-Gene Hypothesis 2.0.

Bourras S, McNally KE, Müller MC, Wicker T, Keller B.

Front Plant Sci. 2016 Mar 1;7:241. doi: 10.3389/fpls.2016.00241. eCollection 2016.

28.

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.

Padula WV, Larson RA, Dusetzina SB, Apperley JF, Hehlmann R, Baccarani M, Eigendorff E, Guilhot J, Guilhot F, Hehlmann R, Mahon FX, Martinelli G, Mayer J, Müller MC, Niederwieser D, Saussele S, Schiffer CA, Silver RT, Simonsson B, Conti RM.

J Natl Cancer Inst. 2016 Mar 4;108(7). doi: 10.1093/jnci/djw003. Print 2016 Jul.

29.

c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia.

Prinzhorn W, Stehle M, Kleiner H, Ruppenthal S, Müller MC, Hofmann WK, Fabarius A, Seifarth W.

Biomark Res. 2016 Mar 2;4:5. doi: 10.1186/s40364-016-0059-2. eCollection 2016.

30.

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.

Miranda MB, Lauseker M, Kraus MP, Proetel U, Hanfstein B, Fabarius A, Baerlocher GM, Heim D, Hossfeld DK, Kolb HJ, Krause SW, Nerl C, Brümmendorf TH, Verbeek W, Fauser AA, Prümmer O, Neben K, Hess U, Mahlberg R, Plöger C, Flasshove M, Rendenbach B, Hofmann WK, Müller MC, Pfirrmann M, Hochhaus A, Hasford J, Hehlmann R, Saußele S.

Leukemia. 2016 Jun;30(6):1255-62. doi: 10.1038/leu.2016.20. Epub 2016 Feb 9.

31.

Mathematical model and calculation to predict the effect of prophylactic plasma transfusion on change in international normalized ratio in critically ill patients with coagulopathy.

Pham HP, Müller MC, Williams LA 3rd, Juffermans NP.

Transfusion. 2016 Apr;56(4):926-32. doi: 10.1111/trf.13447. Epub 2015 Dec 31.

PMID:
26718124
32.

Haematological malignancy in the intensive care unit: microbiology results and mortality.

van Beers EJ, Müller MC, Vlaar AP, Spanjaard L, van den Bergh WM; HEMA-ICU Study Group.

Eur J Haematol. 2016 Sep;97(3):271-7. doi: 10.1111/ejh.12721. Epub 2016 Feb 4.

PMID:
26676382
33.

[Elastic Stable Intramedullary Nailing (ESIN) of Metatarsal Fractures].

Hettchen M, Strauss AC, Pennekamp PH, Burger C, Weber O, Müller MC.

Z Orthop Unfall. 2016 Apr;154(2):148-56. doi: 10.1055/s-0041-109773. Epub 2015 Dec 15. German.

PMID:
26670302
34.

[The "Muffplastik"--a Fasciocutaneous Reconstruction Technique in a Case of Extensive Soft Tissue Defect of the Distal Forearm--Historical Technique or Salvage Procedure?].

Wimmer MD, Philipps HM, Windemuth M, Burger C, Müller MC.

Z Orthop Unfall. 2016 Feb;154(1):77-9. doi: 10.1055/s-0041-107986. Epub 2015 Dec 10. German.

PMID:
26662368
35.

Characteristics and outcomes of patients with a haematological malignancy admitted to the intensive care unit for a neurological event.

Riedijk M, van den Bergh WM, van Vliet M, Kusadasi N, Span LR, Tuinman PR, Arbous MS, Müller MC; HEMA-ICU study group.

Crit Care Resusc. 2015 Dec;17(4):268-73.

PMID:
26640063
36.

Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients.

Deininger MW, Hodgson JG, Shah NP, Cortes JE, Kim DW, Nicolini FE, Talpaz M, Baccarani M, Müller MC, Li J, Parker WT, Lustgarten S, Clackson T, Haluska FG, Guilhot F, Kantarjian HM, Soverini S, Hochhaus A, Hughes TP, Rivera VM, Branford S.

Blood. 2016 Feb 11;127(6):703-12. doi: 10.1182/blood-2015-08-660977. Epub 2015 Nov 24.

37.

Potential diagnostic markers for disseminated intravascular coagulation of sepsis.

Iba T, Ito T, Maruyama I, Jilma B, Brenner T, Müller MC, Juffermans NP, Thachil J.

Blood Rev. 2016 Mar;30(2):149-55. doi: 10.1016/j.blre.2015.10.002. Epub 2015 Nov 6. Review.

PMID:
26574054
38.

Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples.

Boch T, Reinwald M, Postina P, Cornely OA, Vehreschild JJ, Heußel CP, Heinz WJ, Hoenigl M, Eigl S, Lehrnbecher T, Hahn J, Claus B, Lauten M, Egerer G, Müller MC, Will S, Merker N, Hofmann WK, Buchheidt D, Spiess B.

Mycoses. 2015 Dec;58(12):735-45. doi: 10.1111/myc.12424. Epub 2015 Oct 26.

PMID:
26497302
39.

[Bilateral Dislocation Fracture of the Humeral Head (Right AO 11C3.3; Left AO 11A1.3) without Direct Trauma Due to First Clinical Manifestation of Seizure - a Case Report and Review of the Literature].

Ploeger MM, Pennekamp PH, Müller MC, Kabir K, Burger C, Wirtz DC, Schmolders J.

Z Orthop Unfall. 2015 Dec;153(6):643-7. doi: 10.1055/s-0035-1546265. Epub 2015 Oct 15. Review. German.

PMID:
26468921
40.

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.

Gratwohl A, Pfirrmann M, Zander A, Kröger N, Beelen D, Novotny J, Nerl C, Scheid C, Spiekermann K, Mayer J, Sayer HG, Falge C, Bunjes D, Döhner H, Ganser A, Schmidt-Wolf I, Schwerdtfeger R, Baurmann H, Kuse R, Schmitz N, Wehmeier A, Fischer JT, Ho AD, Wilhelm M, Goebeler ME, Lindemann HW, Bormann M, Hertenstein B, Schlimok G, Baerlocher GM, Aul C, Pfreundschuh M, Fabian M, Staib P, Edinger M, Schatz M, Fauser A, Arnold R, Kindler T, Wulf G, Rosselet A, Hellmann A, Schäfer E, Prümmer O, Schenk M, Hasford J, Heimpel H, Hossfeld DK, Kolb HJ, Büsche G, Haferlach C, Schnittger S, Müller MC, Reiter A, Berger U, Saußele S, Hochhaus A, Hehlmann R; SAKK; German CML Study Group.

Leukemia. 2016 Mar;30(3):562-9. doi: 10.1038/leu.2015.281. Epub 2015 Oct 14.

41.

Perioperative management and outcome of fracture treatment in patients with haemophilia without inhibitors.

Strauss AC, Pennekamp PH, Placzek R, Schmolders J, Friedrich MJ, Oldenburg J, Burger C, Müller MC.

Haemophilia. 2016 Jan;22(1):e30-5. doi: 10.1111/hae.12803. Epub 2015 Oct 9.

PMID:
26453567
42.

[Impact of Preoperative Knee Stiffness on the Postoperative Outcome after Total Knee Arthroplasty in Patients with Haemophilia].

Strauss AC, Goldmann G, Schmolders J, Müller MC, Placzek R, Oldenburg J, Wirtz DC, Pennekamp PH.

Z Orthop Unfall. 2015 Oct;153(5):526-32. doi: 10.1055/s-0035-1557768. Epub 2015 Oct 9. German.

PMID:
26451861
43.

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study.

Hochhaus A, Rosti G, Cross NC, Steegmann JL, le Coutre P, Ossenkoppele G, Petrov L, Masszi T, Hellmann A, Griskevicius L, Wiktor-Jedrzejczak W, Rea D, Coriu D, Brümmendorf TH, Porkka K, Saglio G, Gastl G, Müller MC, Schuld P, Di Matteo P, Pellegrino A, Dezzani L, Mahon FX, Baccarani M, Giles FJ.

Leukemia. 2016 Jan;30(1):57-64. doi: 10.1038/leu.2015.270. Epub 2015 Oct 6.

44.

Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.

Fabarius A, Kalmanti L, Dietz CT, Lauseker M, Rinaldetti S, Haferlach C, Göhring G, Schlegelberger B, Jotterand M, Hanfstein B, Seifarth W, Hänel M, Köhne CH, Lindemann HW, Berdel WE, Staib P, Müller MC, Proetel U, Balleisen L, Goebeler ME, Dengler J, Falge C, Kanz L, Burchert A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Spiekermann K, Brümmendorf TH, Edinger M, Hofmann WK, Pfirrmann M, Hasford J, Krause S, Hochhaus A, Saußele S, Hehlmann R; SAKK and the German CML Study Group.

Ann Hematol. 2015 Dec;94(12):2015-24. doi: 10.1007/s00277-015-2494-9. Epub 2015 Sep 18.

PMID:
26385387
45.

Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib.

Wenn K, Tomala L, Wilop S, Vankann L, Hasenbank C, Frank O, Hochhaus A, Giles FJ, Lange T, Müller MC, Koschmieder S, Beier F, Ziegler P, Brümmendorf TH.

Leukemia. 2015 Dec;29(12):2402-4. doi: 10.1038/leu.2015.245. Epub 2015 Sep 15. No abstract available.

PMID:
26369986
46.

Measurement of separase proteolytic activity in single living cells by a fluorogenic flow cytometry assay.

Haaß W, Kleiner H, Müller MC, Hofmann WK, Fabarius A, Seifarth W.

PLoS One. 2015 Aug 12;10(8):e0133769. doi: 10.1371/journal.pone.0133769. eCollection 2015.

47.

Silver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients.

Tokmaji G, Vermeulen H, Müller MC, Kwakman PH, Schultz MJ, Zaat SA.

Cochrane Database Syst Rev. 2015 Aug 12;(8):CD009201. doi: 10.1002/14651858.CD009201.pub2. Review.

PMID:
26266942
48.

Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy: reply.

Müller MC, Juffermans NP.

J Thromb Haemost. 2015 Oct;13(10):1943-4. doi: 10.1111/jth.13068. Epub 2015 Sep 1. No abstract available.

49.

Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality.

Letang E, Müller MC, Ntamatungiro AJ, Kimera N, Faini D, Furrer H, Battegay M, Tanner M, Hatz C, Boulware DR, Glass TR.

Open Forum Infect Dis. 2015 Apr 2;2(2):ofv046. doi: 10.1093/ofid/ofv046. eCollection 2015 Apr.

50.

War Within, War Outside: A Psychoanalytic Account of Delusional Themes in Germany and Israel During the Twentieth Century.

Tzur Bitan D, Müller MC, Keren S, Krieger I, Hornuf L.

J Am Psychoanal Assoc. 2015 Jun;63(3):NP1-7. doi: 10.1177/0003065115594186. No abstract available.

PMID:
26185295

Supplemental Content

Loading ...
Support Center